Embla Medical Hf Forecast, price target & analysts
Embla Medical Hf Target price 2026 - Analyst rating & recommendation
Embla Medical Hf Classifications & Recommendation
Embla Medical Hf Price Target
| Target Price | kr34.68 |
| Price | kr27.25 |
| Potential |
27.27%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Embla Medical Hf 2027 .
The average Embla Medical Hf target price is kr34.68.
This is
27.27%
register free of charge
kr42.00
54.13%
register free of charge
kr29.80
9.34%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Embla Medical Hf to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Embla Medical Hf stock has an average upside potential 2027 of
27.27%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 6.05 | 6.83 |
| 8.63% | 13.06% | |
| EBITDA Margin | 17.61% | 20.65% |
| 2.01% | 17.24% | |
| Net Margin | 8.97% | 9.49% |
| 12.35% | 5.76% |
7 Analysts have issued a sales forecast Embla Medical Hf 2026 . The average Embla Medical Hf sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Embla Medical Hf EBITDA forecast 2026. The average Embla Medical Hf EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Embla Medical Hf Analysts have issued a net profit forecast 2026. The average Embla Medical Hf net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 1.27 | 1.52 |
| 22.12% | 19.69% | |
| P/E | 17.89 | |
| EV/Sales | 2.11 |
7 Analysts have issued a Embla Medical Hf forecast for earnings per share. The average Embla Medical Hf EPS is
This results in the following potential growth metrics and future valuations:
Embla Medical Hf...
Current Embla Medical Hf Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jun 02 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Feb 13 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Feb 04 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jan 26 2026 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jan 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jun 02 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Feb 13 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Feb 04 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jan 26 2026 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jan 25 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
